Alvotech Targets Chinese Biosimilars With Yangtze River Deal

Exclusive Partnership Covers Eight Biosimilar Candidates In China

 
• By David Wallace
  
Business_China
The deal offers access to China for Alvotech’s biosimilars portfolio • Source: Shutterstock

More from Deals

More from Business